Cardiology
Ipamorelin
Research on ipamorelin, a selective growth hormone secretagogue peptide, in pituitary signaling and metabolic studies.
Unknown pathwayAlso known as: Ipamorelin, IPAM, growth hormone secretagogue
11
Clinical questions
0
Claims analyzed
What does the research say about Ipamorelin?
Unknown pathwayBased on 0 claims ( agreements, contradictions)
Topic has no MeSH concept mappings
Stay current on Ipamorelin
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Evidence brief: Ipamorelin
Ipamorelin (also known as Ipamorelin, IPAM, growth hormone secretagogue). Research on ipamorelin, a selective growth hormone secretagogue peptide, in pituitary signaling and metabolic studies.
As of 2026-08-14, the scientific consensus on Ipamorelin is unknown. Topic has no MeSH concept mappings
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/peptide-ipamorelin.
Deterministic synthesis from Synapse's enriched corpus — 51 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Follow the latest Ipamorelin research
Explore every Ipamorelin paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.